位置:成果数据库 > 期刊 > 期刊详情页
HC—NPs对RAW264.7-4T1共培养体系中乳腺癌细胞增殖及凋亡的影响
  • ISSN号:1000-8179
  • 期刊名称:《中国肿瘤临床》
  • 时间:0
  • 分类:R737.33[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]重庆医科大学检验系临床血液学教研室,临床检验诊断学教育部重点实验室,重庆市400016
  • 相关基金:本文课题受国家自然科学基金项目(编号:30971131)资助
中文摘要:

目的:探索联氨基姜黄素纳米脂质体(hydrazinocurcumin—loaded nanopaticles,HC—NPs)通过抑制STAT3(signal transduetion and activators of transcription-3)活化,对RAW264.7—4T1共培养体系中4T1细胞增殖及凋亡的影响。方法:以乳腺癌细胞一巨噬细胞共培养体系中的乳腺癌细胞4T1为研究对象,分PBS对照组和10%NPs对照组、10%HC—NPs处理组。采用检测细胞形态学变化,台盼蓝染色计数细胞存活率,流式细胞仪检测细胞凋亡率及细胞周期变化,Westernblot检测STAT3、p-STAT3、c—MYC、Bcl一2及Bax的蛋白表达水平。结果:刘氏染色发现经10%HC—NPs处理后,4T1细胞形态变圆,台盼蓝染色计数显示细胞存活率减低,且与对照组有显著性差异(P〈0.05);流式细胞仪检测发现HC—NPs处理组细胞凋亡率为(24.21±2.37)%,细胞周期结果显示HC—NPs组处理的细胞主要阻滞在GdM期为(63.70±2.53)%,与对照组有显著性差异(P〈0.05);Westernblot检测显示,HC—NPs组4T1细胞的p-STAT3、c—MYC表达明显减少,Bcl-2/Bax比值下降,而总STAT3水平无明显变化。结论:HC—NPs能通过抑制STAT3活化(p—STAT3),影响细胞增殖、凋亡相关基因,抑制共培养体系中乳腺癌细胞4T1的增殖,促进其凋亡。

英文摘要:

Objective: To investigate the effects of hydrazinocurcumin-loaded nanoparticles ( HC-NPs ) on the proliferation and apoptosis of breast cancer 4T 1 cells in coculture conditions through the inhibition of the signal transducer and activator of transcription 3 ( STAT3 ) signal pathway activation. Methods: Mouse breast cancer 4T1 cells in coculture conditions were divided into three groups, namely, the PBS control, 10% NP control, and 10% HC-NP treatment groups. Morphological investigation was conducted via Liu staining, and the survival ratio was determined via trypan blue staining. Cell cycle and apoptosis were detected using flow cytometry. Western blot analysis was used to determine the expression of STAT3, phosphorylation STAT3 ( pSTAT3 ), c-MYC, B-cell lymphoma 2 ( Bcl-2 ), and Bcl-2-associated X protein ( Bax ). Results: Liu staining results show that the shape of the HC-NP-treated 4T1 ceils was spherical. Moreover, trypan blue staining shows that the survival ratio of the treated cells was significantly decreased compared with that of the control. Flow cytometry results show that the apoptosis rates of the HC-NP treatment groups was 24.21%±2.37% ( P 〈 0.05 ), whereas that of The cells in the GIM phase increased ( 63.70%±2.53%, P 〈 0.05 ). Western blot analysis indicates that p-STAT3, c-MYC, and the ratio of Bcl-2/Bax expression decreased. However, that of total STAT3 showed no significant difference with that of the control. Conclusion: HC-NPs can inhibit the proliferation and promote the apoptosis of breast cancer 4T1 cells in coculture conditions, possibly by inhibiting STAT3 activity and affecting the genes related to proliferation and apoptosis.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国肿瘤临床》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中国抗癌协会
  • 主编:郝希山
  • 地址:天津市河西区体院北环湖西路天津肿瘤医院C楼3层
  • 邮编:300060
  • 邮箱:cjco@cjco.cn
  • 电话:022-23527053
  • 国际标准刊号:ISSN:1000-8179
  • 国内统一刊号:ISSN:12-1099/R
  • 邮发代号:6-18
  • 获奖情况:
  • 1997、1999、2001三次获中国科协优秀期刊奖励基金,2001年获天津市科技期刊一等奖,1996年获中国科协优秀期刊三等奖,2011年天津市优秀期刊提名奖,2011年中国精品科技期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:37940